Skip to main content

Evonik closes PeroxyChem buy

Evonik has closed the $640 million acquisition of PeroxyChem from One Equity Partners, after a lawsuit to block it filed by the Federal Trade Commission in August 2019 was rejected.

Allessa plant to be upgraded

WeylChem has announced that it is investing a sum “in the range of high single-digit millions euros” to upgrade a multi-purpose plant at the site of its Allessa custom and toll manufacturing subsidiary.

Lonza swings to pharma

Lonza has announced results for 2019, in which its growth was entirely driven by the Pharma Biotech & Nutrition division on which it will base its future.

Regulatory alignment vital, says CBA

The Chemical Business Association, which represents chemical distributors in the UK, has joined other associations in responding critically to Chancellor Sajid Javid’s recent statement that there would be no regulatory alignment with the EU following Brexit.

Lanxess pushes forward site digitisation

Lanxess has implemented Software AG’s TrendMiner self-service analytics system for time-series data in about two thirds of its 120 plants, including all of its major production sites in Germany, Belgium, the US and India. Only smaller plants with less complex processes are not yet covered, the company said.

Subscribe to Current issue




AMRI banner advert